Research & Treatment News

Breaking News: Viekira Pak Approved for Hep C

Dec 23, 2014 66 Comments

Placing AbbVie on the list of top pharmaceutical competitors, the FDA has just approved the Viekira Pak for treating Hepatitis C genotype 1.

Daclatasvir Gets Denied

Dec 3, 2014

Find out why additional data is needed before approval is met.

Hold Onto Your Hats: Has a Vaccine for Hepatitis C Arrived?

Nov 25, 2014

Learn more about the development of this Hepatitis C vaccine, and who the efficacy of the vaccine is being tested on in two sites in the USA.

A Win for Liver Transplant Patients with Hepatitis C

Nov 25, 2014 4 Comments

AbbVie's Hepatitis C drug recently cured 97% patients in a transplant study.

Second All-Oral Hep C Treatment Available: Less Expensive

Nov 13, 2014 13 Comments

Olysio has been approved, in combination with Sovaldi, for the treatment of Hepatitis C. It is approximately $30,000 less than Harvoni (both of which consist of 12 weeks of therapy).

Harvoni Is Here: The Once-a-Day, Single Hep C Pill

Nov 12, 2014 362 Comments

Interferon-free and ribavirin-free treatment has finally arrived, but someone has to pay for this miracle Hepatitis C pill.

A New Hepatitis C Treatment: No Interferon or Ribavirin Required!

Oct 27, 2014 13 Comments

The side effects of interferon and ribavirin therapies for the treatment of Hepatitis C can be monstrous: nausea, fatigue, insomnia, diarrhea, depression and itchy skin. Learn about a new treatment – Harvoni –that does not require the use of interferon or ribavirin.